The World According to Boyar brings top investors, best selling authors, and market newsmakers to show you the smartest ways to uncover value in the stock market.
The World According To Boyar - Episode 16 - David M. Rubenstein
Biography: David M. Rubenstein is a Co-Founder and Co-Executive Chairman of The Carlyle Group, one of the world’s largest and most successful private investment firms. Mr. Rubenstein co-founded the firm in 1987. Since then, Carlyle has grown into a...
The World According To Boyar - Episode 15 - Sir Martin E. Franklin
Biography:Sir Martin E. Franklin is the Founder and CEO of Mariposa Capital, a Miami based family investment firm focused on long term value creation across various industries. Mr. Franklin serves as Founder and Executive Chairman of Element Solutions...
The World According To Boyar - Episode 14: Brandon Ridenour
Biography: William B. (Brandon) Ridenour is CEO of ANGI Homeservices (ANGI) and also serves on the Board of Directors. Prior to assuming the role of CEO of ANGI Homeservices, Mr. Ridenour served as the Chief Product Officer of ANGI Homeservices and as...
The World According To Boyar - Episode 13: Caleb Silver
Biography:Caleb began his career producing wildlife documentaries in South America and the American southwest. His career in business news began at Bloomberg, where he worked as a senior television producer and was nominated for a 2003 Emmy Award.Caleb...
The World According to Boyar - Episode 12: Mellody Hobson
BiographyAs Co-CEO, Mellody is responsible for all firm-wide management, including strategic planning and growth as well as every aspect of Ariel’s business beyond research and portfolio management. Prior to her formal appointment to Co-CEO, Mellody...
The World According to Boyar - Episode 11 - Kenneth L. Davis, MD
Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, is widely recognized as a visionary leader who has guided the institution on a strong and dramatic growth trajectory. In 2013, the Mount Sinai Health System was formed by the combination of The Mount Sinai Medical Center and Continuum Health Partners, becoming one of the largest nonprofit systems in the country with $8 billion in revenue, 42,000 employees, eight hospitals, and more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Prior to becoming CEO, Dr. Davis spent 15 years as Chair of Mount Sinai’s Department of Psychiatry. He was the first Director for many of the institution’s research entities, including Mount Sinai’s National Institutes of Health (NIH)-funded Alzheimer’s Disease Research Center, the Schizophrenia Biological Research Center at the Bronx Veterans Affairs Medical Center, the Silvio Conte Neuroscience Center to study schizophrenia, and the Seaver Autism Center for Research and Treatment. Additionally, he received one of the first and largest program project grants for Alzheimer’s disease research from the NIH.
The interview discusses:
How Dr. Davis led one of the greatest financial turnarounds in medical history;
The reasons why healthcare keeps becoming more expensive along with solutions on how to decrease costs without sacrificing care;
Why drug pricing should be a trade issue;
Why the current patent system discourages pharmaceutical innovation;
What “value based” medicine is and why insurance companies and hospitals should consider adopting it;
Why the National Institutes of Health is so vital to drug discovery;
His thoughts on CVS’s strategy of becoming an integrated health care provider;
What serious healthcare problem he sees getting worse which he believes has the potential to bankrupt the entire Medicare system;
And much more….
Customer ReviewsSee All
Fantastic podcast. Interesting and intelligent. Every time I listen to Boyar I come away feeling like it was time well spent.
Great podcast !!!
I found this to be extremely insightful
Thoroughly enjoyed the topics and the guests
All the Boyar podcasts offer insightful comments about investment strategies. I particularly appreciate the balanced and straightforward structure and delivery of each of the podcast. The topics are smart and offer valuable perspectives on investment. Focused and interesting. Would highly recommend listening!